* CVRx Inc CVRX.OQ reported a quarterly adjusted loss
of 44
cents per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of -51
cents. The mean expectation of six analysts for the quarter was
for a loss of 54 cents per share. Wall Street expected
results to range from -57 cents to -49 cents per share.
* Revenue rose 57.5% to $11.31 million from a year ago;
analysts
expected $11.14 million.
* CVRx Inc's reported EPS for the quarter was a loss of 44
cents.
* The company reported a quarterly loss of $9.16 million.
* CVRx Inc shares had fallen by 12.2% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 4.7%
in the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for CVRx Inc is
$31.00
This summary was machine generated from LSEG data January 25 at
10:00 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.54 -0.44 Beat
Sep. 30 2023 -0.58 -0.43 Beat
Jun. 30 2023 -0.58 -0.56 Beat
Mar. 31 2023 -0.56 -0.55 Beat